Mundipharma, a network of independent pharma companies, has bought Spanish biosimilars development company Cinfa Biotech. The deal will see Mundipharma, which includes NAPP Pharmaceuticals in the ...
Cinfa Biotech meets all these demands. The company is the specialist biosimilar unit of Cinfa Group, a leading Spanish pharmaceutical firm. The group structure gives Cinfa Biotech the support of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback